Penumbra Inc Asset Resilience Ratio
Penumbra Inc asset resilience ratio. Penumbra Inc (PEN) has an Asset Resilience Ratio of 22.97% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See PEN defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Penumbra Inc (2013–2025)
Asset resilience ratio of Penumbra Inc from 2013 to 2025. This chart shows how Penumbra Inc's Asset Resilience Ratio has changed over time. Read PEN total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Penumbra Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Penumbra Inc's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $453.52 Million | 22.97% |
| Total Liquid Assets | $453.52 Million | 22.97% |
Asset Resilience Insights
- Good Liquidity Position: Penumbra Inc maintains a healthy 22.97% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Penumbra Inc Industry Peers by Asset Resilience Ratio
Compare Penumbra Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Vitrolife AB
ST:VITR |
Medical Devices | 7.27% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085 |
Medical Devices | 7.69% |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298 |
Medical Devices | 2.82% |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580 |
Medical Devices | 10.74% |
|
TAIDOC TECHNOLOGY CORP
TW:4736 |
Medical Devices | 23.03% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 3.90% |
Penumbra Inc Asset Resilience Ratio by Year (2013–2025)
Penumbra Inc asset resilience ratio by year from 2013 to 2025. The table below shows the annual Asset Resilience Ratio data for Penumbra Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 29.83% | $544.82 Million | $1.83 Billion | +7.64pp |
| 2024-12-31 | 22.18% | $340.13 Million | $1.53 Billion | +3.60pp |
| 2023-12-31 | 18.58% | $289.19 Million | $1.56 Billion | +4.87pp |
| 2022-12-31 | 13.72% | $188.03 Million | $1.37 Billion | -6.77pp |
| 2021-12-31 | 20.48% | $254.88 Million | $1.24 Billion | -11.70pp |
| 2020-12-31 | 32.18% | $264.83 Million | $822.98 Million | +3.74pp |
| 2019-12-31 | 28.44% | $189.39 Million | $665.90 Million | -10.57pp |
| 2018-12-31 | 39.01% | $200.89 Million | $515.01 Million | -6.01pp |
| 2017-12-31 | 45.02% | $214.59 Million | $476.67 Million | +3.25pp |
| 2016-12-31 | 41.77% | $128.75 Million | $308.25 Million | -7.22pp |
| 2015-12-31 | 48.99% | $129.26 Million | $263.85 Million | +9.24pp |
| 2014-12-31 | 39.75% | $48.25 Million | $121.38 Million | +26.34pp |
| 2013-12-31 | 13.42% | $9.54 Million | $71.15 Million | -- |
About Penumbra Inc
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombecto… Read more